Home
>
US Stocks
>
I-Mab - ADR
I-Mab - ADR
IMAB

I-Mab - ADR

$65.544.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
68.96
Today Low/High
64.34 / 70.55
52 Week Low/High
$29.08 / $85.4
Market Cap
$5.08B

Company Details

I-Mab is an innovation-driven global biotech company focusing on discovery, development and soon commercialization of novel and highly differentiated biologics in immuno-oncology therapeutic area. The Company's mission is to bring transformational medicines to patients around the world through drug innovation. I-Mab's globally competitive pipeline of more than 15 clinical and pre-clinical stage drug candidates is driven by its internal R&D capability and global licensing partnerships, based on the Company's unique Fast-to-Proof-of-Concept and Fast-to-Market pipeline development strategies. The Company is now rapidly progressing from a clinical stage biotech company to a fully integrated global biopharmaceutical company with cutting-edge global R&D capabilities, a world-class GMP manufacturing facility and commercialization capability. I-Mab has established its global footprint in Shanghai (headquarters), Beijing, Hangzhou and Hong Kong in China, and Maryland and San Diego in the United States.
Organisation
I-Mab - ADR
Industry
Health Technology

Discover more

Frequently Asked Questions

What is I-Mab - ADR share price today

Can Indians buy I-Mab - ADR shares?

How can I buy I-Mab - ADR shares from India?

Can Fractional shares of I-Mab - ADR be purchased?

What are the documents required to start investing in I-Mab - ADR stocks?

We are a SEBI registered investement advisor